MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$8,690,667
EPS
-$2.71
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
Research and development
1,376,861 1,295,286* 922,857
General and administrative
1,715,639 1,946,495* 1,020,154
Total operating expenses
3,092,500 3,241,781 1,943,011
Loss from operations
-3,092,500 -3,241,781* -1,943,011
Change in fair value of warrant liability
--325* -611
Other income (expense), net
83,449 49,335* 35,224
Total other income (expense), net
83,449 49,660* 35,835
Net loss
-3,009,051 -3,192,121* -1,907,176
Deemed dividends
5,681,616 -2,357,698* 2,769,742
Net loss attributable to common stockholders
-8,690,667 -834,423 -4,676,918
Basic EPS
-2.71 0.595 -1.77
Diluted EPS
-2.71 0.595 -1.77
Basic Average Shares
3,207,720 -1,403,163 2,644,733
Diluted Average Shares
3,207,720 -1,403,163 2,644,733
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$8,690,667 Other income(expense), net$83,449 Deemed dividends$5,681,616 Net loss-$3,009,051 Total other income(expense), net$83,449 Loss from operations-$3,092,500 Total operatingexpenses$3,092,500 General andadministrative$1,715,639 Research and development$1,376,861

REVELATION BIOSCIENCES, INC. (REVB)

REVELATION BIOSCIENCES, INC. (REVB)